CIRCULATING PCSK9 IS NOT ASSOCIATED WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITY

被引：0
|
作者：
Silbernagel, Guenther [1 ]
Scharnagl, Hubert [1 ]
Kleber, Marcus [1 ]
Stojakovic, Tatjana [1 ]
Maerz, Winfried [1 ]
机构：
[1] Med Univ Graz, Graz, Austria
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2017年 / 69卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(17)35051-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1133M-11
引用
收藏
页码：1662 / 1662
页数：1
相关论文
共 50 条
  • [1] Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials
    Dicembrini, I.
    Giannini, S.
    Ragghianti, B.
    Mannucci, E.
    Monami, M.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (09) : 1029 - 1039
  • [2] Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials
    I. Dicembrini
    S. Giannini
    B. Ragghianti
    E. Mannucci
    M. Monami
    [J]. Journal of Endocrinological Investigation, 2019, 42 : 1029 - 1039
  • [3] LOW LDL CHOLESTEROL BY PCSK9 VARIATION REDUCES CARDIOVASCULAR AND ALL-CAUSE MORTALITY - MENDELIAN RANDOMIZATION OF 109,566 INDIVIDUALS FROM COPENHAGEN
    Benn, M.
    Tybjaerg-Hansen, A.
    Nordestgaard, B. G.
    [J]. ATHEROSCLEROSIS, 2018, 275 : E101 - E102
  • [4] Liver fat accumulation is associated with circulating PCSK9
    Ruscica, Massimiliano
    Ferri, Nicola
    Macchi, Chiara
    Meroni, Marica
    Lanti, Claudia
    Ricci, Chiara
    Maggioni, Marco
    Fracanzani, Anna Ludovica
    Badiali, Sara
    Fargion, Silvia
    Magni, Paolo
    Valenti, Luca
    Dongiovanni, Paola
    [J]. ANNALS OF MEDICINE, 2016, 48 (05) : 384 - 391
  • [5] Prediabetes associated with increased risk of cardiovascular and all-cause mortality
    Farham, Bridget
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2017, 107 (01): : 20 - +
  • [6] Is Obstructive Sleep Apnea Associated with Cardiovascular and All-Cause Mortality?
    Ge, Xiahui
    Han, Fengfeng
    Huang, Yanxi
    Zhang, Yue
    Yang, Tianyun
    Bai, Chong
    Guo, Xuejun
    [J]. PLOS ONE, 2013, 8 (07):
  • [7] Non adherence to cardiovascular preventive guidelines is associated with all-cause and cardiovascular mortality
    Seguro, F.
    Bongard, V.
    Berard, E.
    Ruidavets, J. B.
    Taraszkiewicz, D.
    Galinier, M.
    Carrie, D.
    Ferrieres, J.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 195 - 196
  • [8] BINDING OF PCSK9 TO CIRCULATING LDL: EFFECT OF PCSK9 MONOCLONAL ANTIBODIES ON THE LDL-BOUND PCSK9?
    De Stefano, D.
    Baragetti, A.
    Baragetti, A.
    Macri, N.
    Tavori, H.
    Fazio, S.
    Catapano, A. L.
    [J]. ATHEROSCLEROSIS, 2018, 275 : E101 - E101
  • [9] Cadmium exposure and all-cause mortality and cardiovascular cause
    不详
    [J]. ENVIRONNEMENT RISQUES & SANTE, 2013, 12 (03): : 208 - 209
  • [10] Circulating proprotein convertase subtilisin-kexin type 9, all-cause mortality, and cardiovascular mortality: The Ludwigshafen Risk and Cardiovascular Health study
    Silbernagel, Guenther
    Scharnagl, Hubert
    Kleber, Marcus E.
    Stojakovic, Tatjana
    Maerz, Winfried
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (10) : 1095 - 1101
12345